The Almelo Research Center (ARC) is a fully established facility for our in-house and custom product R&D services. The ARC was established in 2012 with a team of 8 scientists and has since grown to more than 35 scientists and engineers, including 9 PhDs. The center is supported by a highly experienced leadership team with extensive R&D expertise across leading Indian pharmaceutical companies such as Wockhardt, Lupin, Tata Pharma, Sun Pharma, Dai-Ichi Laboratories, Ranbaxy, and Alembic.
Our custom research service capabilities include
- Process Development and Optimization based on QbD Principles
- Development of Analytical Methods
- Process Scale-up and Technology Transfer
- Impurity Isolation, Synthesis and Characterization
- Genotoxicity Evaluation of Impurities
Send an email to enquiries@almelochem.com for more information regarding custom R&D services.